HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-07-26Clinical Trial Update: Supportive Therapy for Adherence to ART(STAART) [NA]
Completed status for a clinical trial evaluating supportive therapy to improve adherence to antiretroviral therapy in HIV infection. The spo…
-
CLINICAL_TRIALS trial_result · 2007-07-18Clinical Trial Update: Phase I/II, Open-Label Trial of Three Monoclonal Antibodies [Phase 1, Phase 2]
Update on a completed Phase I/II open-label trial evaluating three monoclonal antibodies for HIV infection.
-
CLINICAL_TRIALS research · 2007-07-10Clinical Trial Update: A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis [NA]
A clinical trial assessing nitazoxanide for treatment of cryptosporidiosis, including infections in individuals with HIV; the current status…
-
CLINICAL_TRIALS trial_result · 2007-07-03Clinical Trial Update: Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects [Phase 2]
A Phase 2 clinical trial comparing Racivir and Lamivudine in treatment-experienced HIV subjects has completed.
-
CLINICAL_TRIALS trial_result · 2007-07-03Clinical Trial Update: Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR) [Phase 3]
Phase 3 feasibility trial of a once-daily antiretroviral regimen for HIV infection has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-07-03Clinical Trial Update: Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207) [Phase 3]
Phase 3 trial ANRS 1207 evaluated a once-daily fixed-dose triple regimen of tenofovir disoproxil fumarate, emtricitabine, and efavirenz in H…
-
FDA approval · 2007-06-29FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA has approved a supplemental application for KALETRA (lopinavir/ritonavir) from AbbVie Inc. The notice indicates a supplemental appro…
-
FDA approval · 2007-06-29FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie Inc. This action indicates an update to th…
-
CLINICAL_TRIALS trial_result · 2007-06-29Clinical Trial Update: Pediatric Nevirapine Resistance Study [Phase 3]
Phase 3 pediatric study evaluating nevirapine resistance in HIV/AIDS patients; the trial status is currently unknown.
-
CLINICAL_TRIALS research · 2007-06-29Clinical Trial Update: Preventing Unplanned Pregnancies in HIV Infected Zambian Couples [NA]
This clinical trial registry entry describes a study aimed at preventing unplanned pregnancies among HIV-infected couples in Zambia; the cur…
-
CLINICAL_TRIALS trial_result · 2007-06-28Clinical Trial Update: ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency [NA]
This trial update notes a completed study (NCT00493506) evaluating ProAlgaZyme algae infusion for immunodeficiency, with HIV infection and H…
-
FDA approval · 2007-06-19FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Zidovudine from Aurobindo Pharma Limited, updating an existing Zidovudine product.
-
CLINICAL_TRIALS trial_result · 2007-06-14Clinical Trial Update: Marijuana for HIV-Related Peripheral Neuropathy [Phase 1, Phase 2]
This update describes a completed Phase 1/2 clinical trial evaluating cannabis (marijuana) for HIV-related peripheral neuropathy.
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients [Phase 2]
This clinical trial update reports Phase 2 results for treating chronic hepatitis C in HIV-infected patients with pegylated interferon alfa-…
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Pravastatin and Protease Inhibitors in HIV-Infected Patients [Phase 2]
Phase 2 trial evaluating the safety and potential lipid-lowering efficacy of pravastatin in HIV-infected patients taking protease inhibitors…
-
CLINICAL_TRIALS trial_result · 2007-06-11Clinical Trial Update: Effects of Creatine and Resistance Exercise Training in People With HIV Infection [Phase 2]
This Phase 2 trial studied the effects of creatine supplementation together with resistance exercise training in individuals with HIV infect…
-
CLINICAL_TRIALS trial_result · 2007-06-07Clinical Trial Update: Treatment of Hyperglycaemia and Insulin Resistance in HIV Infected Patients [NA]
A completed clinical trial sponsored by University Medical Centre Ljubljana evaluating treatment of hyperglycaemia and insulin resistance in…
-
CLINICAL_TRIALS trial_result · 2007-05-25Clinical Trial Update: Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients [Phase 1]
Phase 1 clinical trial assessing the effect of an anti-inflammatory drug on gut mucosa in HIV-infected patients has completed.
-
FDA approval · 2007-05-21FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate) to update its labeling.
-
FDA approval · 2007-05-14FDA Approved: APTIVUS — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Aptivus (tipranavir) filed by Boehringer Ingelheim Pharmaceuticals. The approval indicates a…
-
FDA approval · 2007-05-07FDA Approved: ZIAGEN — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for ZIAGEN (abacavir sulfate) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2007-04-30Clinical Trial Update: 2NN & CHARM Long-Term Follow-up Study [Phase 4]
This Clinical Trial Update reports the long-term follow-up results for HIV-infected participants in the Phase 4 2NN and CHARM studies. The s…
-
FDA approval · 2007-04-25FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
FDA approved a supplemental application for Prezista (darunavir) submitted by Janssen Products LP.
-
CLINICAL_TRIALS trial_result · 2007-04-24Clinical Trial Update: Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection [Phase 4]
Phase 4 trial results report virological and clinical efficacy of tenofovir disoproxil fumarate and emtricitabine in HIV/HBV co-infected pat…
-
CLINICAL_TRIALS research · 2007-04-24Clinical Trial Update: Succinylated Human Serum Albumin (Suc-HSA) for HIV-1 Infection [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating succinylated human serum albumin (Suc-HSA) for HIV infection has been completed.